期刊文献+

血管内皮生长因子-C反义寡核苷酸对胰腺癌淋巴管及血管生成的影响 被引量:5

Effect on lymphangiogenesis and angiogenesis of pancreatic cancer with antisense oligonucleotide of vascular endothelial growth factor C
原文传递
导出
摘要 目的观察血管内皮生长因子(VEGF)-C反义寡核苷酸对胰腺癌裸鼠原位种植瘤模型淋巴管及血管生成的影响。方法建立人胰腺癌细胞株panc-1裸鼠原位种植瘤模型,将动物随机分为磷酸盐缓冲液(PBS)对照组(A组)、错义对照组(B组)和反义VEGF-C干预组(C组),每组10只,寡核苷酸用量为每次10 mg/kg体重,隔日1次,每周3次,共3周。建模4周后,处死动物,留取血清和瘤体标本,采用酶联免疫吸附试验(ELISA)、免疫组织化学染色法检测反义VEGF-C干预对VEGF-C分泌水平及种植瘤淋巴管和血管生成的影响。结果A、B和C组血清VEGF-C的蛋白表达水平分别为(237.5±41.5)、(221.5±52.3)、(108.6±14.9)ng/L,C组较A、B组明显为低(P<0.01);3组种植瘤内淋巴管密度分别为13.8±2.1、12.4±1.9和4.2±1.6,C组较A、B组显著减少(P<0.01);3组种植瘤内微血管密度分别为27.5±8.7、25.9±4.2和19.4±5.6,组间差异无统计学意义(P>0.05)。结论反义寡核苷酸干预可以显著降低胰腺癌裸鼠原位种植瘤模型VEGF-C的表达水平,并对其淋巴管生成具有抑制作用。 Objective To investigate the effect on lymphangiogenesis and angiogenesis of orthotopic implantation of pancreatic cancer with antisense oligonucleotide (ASODN) of vascular endothelial growth factor C(VEGF-C). Methods Antisense and scamble oligonucleotide of vascular endothelial growth factor C were constructed. Establishment of the model in nude mice with orthotopic implantation for the human pancreatic cancer cell line panc-1. Thirty nude mices were randomized into 3 groups: PBS control group(group A),scramble control group(group B) and antisense group(group C). All nude mices were treated once 2 days as 3 times per week, for 3 weeks(oligonucleotide 10mg/kg/time). After treatment was completed, the exocrine of VEGF-C and lymphangiogenesis and angiogenesis of pancreatic cancer were detected by ELISA and immunohistochemistry. Results With treatment of ASODN, the exocrine of VEGF-C was inhibited significantly in the serum (P 〈 0.05). The levels were (237.5 ± 41.5 ), (221.5± 52.3) and (108.6 ± 14.9) ng/L in group A, B and C respectively. Meanwhile, the lymph vessel density was decreased significantly (P 〈 0.05), 13.8 ± 2.1,12.4 ± 1.9 and 4.2 ± 1.6 in each group respectively. Though the microvessel densities were tended to decrease, 27.5 ±8.7, 25.9 ±4.2 and 19.4 ± 5.6 in each group respectively, but there wre not different statisticaly (P 〉 0.05). Conclusion The antisense oligonucleotide of VEGF-C decrese the level of VEGF-C in nude mice of orthotopic implantation of pancreatic cancer, and have inhibition effect on lymphangiogenesis.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2006年第9期1095-1097,共3页 Chinese Journal of Experimental Surgery
基金 湖北省自然科学基金(2006ABA126) 湖北省科技攻关资助项目(2006AA301C30)
关键词 胰腺肿瘤 血管内皮生长因子C 淋巴管生成 血管生成 基因治疗 Pancreatic neoplasms Vascular endothelial growth factor C Lymphangiogenesis Angiogenesis Gene therapy
  • 相关文献

参考文献9

  • 1Tang RF, Itakura J, Aikawa T, et al. Overexpression of lymphangiogenic growth factor VEGF-C in human pancreatic cancer. Pancreas,2001,22 : 285-292.
  • 2Skobe M,Hamberg LM,Alitalo K, et al. Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma. Am J Pathol, 2001,159 : 893-903.
  • 3Weidner N. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol, 1995,147 : 9-19.
  • 4李凯,陶京,王春友.胰腺癌淋巴管生成与血管内皮生长因子C的关系[J].中华实验外科杂志,2006,23(1):16-17. 被引量:18
  • 5Berger AC, Watson JC,Rose EA, et al. The meastatic/examined lymph node ratio is an important progonostic factor after pancreatieoduodeneetomy for pancreatic adenocarcinoma. Am Surg, 2004,70 : 235-240.
  • 6Saaristo A, Alitalo K. Lymphangiogenic gene therapy with minimal blood vascular side effects. J Exp Med, 2002,196 : 719-730.
  • 7Hotz HG, Hines OJ, Masood R, et al. VEGF antisense therapy inhibits tumor growth and improves survival in experimental pancreatic cancer.Surgery, 2005,137 : 192-199.
  • 8Dass CR1. Liposome-mediated delivery of oligodeoxynueleotides in vivo. Drug Delivery, 2002,9 : 169-180.
  • 9Joukov V, Sorsa T, Kumar V, et al. Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO, 1997, 16: 3898-3911.

二级参考文献5

  • 1Yeo CJ, Cameron JL, Sohn TA, et al. Six hundred fifty consecutive pancreaticoduoden-Ectomies in the 1990s. Ann Surg, 1997, 266: 248-260.
  • 2Joukov V, Kalkkinen N, Alitalo K, et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Fit4 (VEGFR-3) and KDR(VEGFR-2) receptor tyrosine kinases. EMBO J, 1996, 15: 290-298.
  • 3Weidner N. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol, 1995, 147: 9-19.
  • 4Furudoi A, Tanaka S, Haruma K, et al. Clinical significance of vascular endothelial growth factor C expression and angioganesis at the deepest invasive site of advanced colorectal carcinoma. Oncology, 2002,62:157-166.
  • 5邵春奎,朱正纲,苏祖兰,王瑞年,尹浩然,林言箴.检测胃癌组织中多基因表达的临床病理意义[J].中华实验外科杂志,2000,17(4):300-301. 被引量:8

共引文献17

同被引文献48

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部